|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-2-19
|
|
pubmed:abstractText |
The purpose of this study was to attain a new landmark in the area of selective serotonin reuptake inhibitor therapy during lactation by establishing a basis for interpreting infant serum concentrations and for minimizing infant exposure in the absence of treatment-emergent side effects.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0160-6689
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
64
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
73-80
|
|
pubmed:dateRevised |
2008-9-6
|
|
pubmed:meshHeading |
pubmed-meshheading:12590627-Breast Feeding,
pubmed-meshheading:12590627-Child Development,
pubmed-meshheading:12590627-Chromatography, High Pressure Liquid,
pubmed-meshheading:12590627-Depressive Disorder,
pubmed-meshheading:12590627-Female,
pubmed-meshheading:12590627-Humans,
pubmed-meshheading:12590627-Infant, Newborn,
pubmed-meshheading:12590627-Lactation,
pubmed-meshheading:12590627-Milk, Human,
pubmed-meshheading:12590627-Pregnancy,
pubmed-meshheading:12590627-Serotonin Uptake Inhibitors,
pubmed-meshheading:12590627-Sertraline
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations.
|
|
pubmed:affiliation |
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta GA, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
